Catalyst Biosciences (CBIO) Reports Q2 Loss of $0.42/Share

Catalyst Biosciences (NASDAQ: CBIO) reported Q2 EPS of ($0.42), versus ($4.60) reported last year.

For earnings history and earnings-related data on Catalyst Biosciences (CBIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins